Orion Therapeutics
UEI: REU9AQW7EST1
• CAGE: 9DSC5
Overview
Awardee Type
Parent
Name
Orion Therapeutics
Website
Headquarters
Knoxville, TN
United States
United States
Most Recent Award
Sept. 15, 2025
Calculating
Federal grant recipient
ORION THERAPEUTICS INC.
(UEI REU9AQW7EST1, CAGE 9DSC5)
is headquartered in Knoxville TN.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in May 2022 and
federally registered in
October 2022.
Federal Award Analysis
Orion Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ORION THERAPEUTICS INC.
UEI
REU9AQW7EST1
CAGE Code
9DSC5
Primary NAICS
SBA Certifications
None
Self Certifications
For Profit Organization
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 1, 2022
Initial Registration
Oct. 12, 2022
Last Registration
Feb. 18, 2025
Registration Activation
Feb. 18, 2025
Registration Expiration
Feb. 14, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No